New balloon could keep leg arteries open longer
NCT ID NCT05734157
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special balloon coated with the drug everolimus to treat blockages in the leg's main arteries. The balloon is inflated inside the artery to push the blockage open and release the drug to help prevent the artery from narrowing again. The trial included 75 people with blocked or narrowed femoral or popliteal arteries. The goal was to see if the balloon is safe and effective at keeping the artery open and reducing the need for repeat treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- everolimus-coated balloon
- What this could lead to
- If successful, this could provide a better way to treat blocked leg arteries, reducing the chance of repeat blockages and the need for further procedures.
- What could go wrong
- This is a first-in-human study with only 75 participants, so results may not apply to everyone. The balloon may not keep arteries open as hoped, and there are risks like vessel damage or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMORAL ARTERY OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinique Pasteur
Toulouse, 31300, France
-
DIAKO Krankenhaus Flensburg
Flensburg, 24939, Germany
-
Hôpital Nord Laennec - CHU de Nantes
Saint-Herblain, 44800, France
-
Hôpital Paris Saint Joseph
Paris, 75014, France
-
Institut für Radiologie, Kinderradiologie und interventionelle Therapie
Berlin, 12351, Germany
-
Jüdisches Krankenhaus Berlin
Berlin, 13347, Germany
-
Polyclinique Les Fleurs
Ollioules, 83190, France
-
Romed Klinikum Rosenheim
Rosenheim, 83022, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.